House Bill HB 2076 Marijuana Decriminalization Bill needs cosponsors

Representative Ed Gainey has introduced legislation, House Bill 2076, to amend the state’s controlled substances act so that minor marijuana possession offenses are considered a non-criminal offense. But the bill needs support from all across the commonwealth. Please contact your representative and ask them to become a cosponsor.  You can contact your Representative by sending an email using this link





Session of





Amending the act of April 14, 1972 (P.L.233, No.64), entitled “An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act,” further providing for prohibited acts and penalties.

The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:

Section 1. Section 13(g) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended December 14, 1984 (P.L.988, No.200), is amended to read:

Section 13. Prohibited Acts; Penalties.–* * *

(g) Any person who violates clause (31) of subsection (a) is guilty of a [misdemeanor] summary offense and upon conviction thereof shall be [sentenced to imprisonment not exceeding thirty days, or] ordered to pay a fine not exceeding [five hundred dollars ($500), or both.] one hundred dollars ($100). A conviction under this subsection shall not trigger the mandatory license suspension provisions under 75 Pa.C.S. § 1532(c) (relating to suspension of operating privilege).

* * *

Section 2. This act shall take effect in 60 days.

Pittsburgh NORML endorses US Cannabis’ seminars coming to Pittsburgh June 11th & 12th


Pittsburgh NORML endorses US Cannabis’ seminars coming to Pittsburgh June 11th & 12th

US Cannabis Pharmaceutical Research and Development is honored to announce a strategic partnership with Pittsburgh NORML for sponsorship of the US Cannabis Medical Marijuana Business Seminar Series being held in Pittsburgh June 11th and 12th. Registration for all seminars is at

“We only work with the best, and NORML sets the standard for professionalism and results. They are the best marijuana advocacy group in the country. It’s an honor to have them on our team,” said Michael Patterson, CEO of US Cannabis. “NORML has fought tirelessly for adults to have access to Marijuana without persecution. We want to implement their mission through educating Pennsylvania’s best and brightest on the new Medical Marijuana law to facilitate successful marijuana commerce in the Keystone state.”

“It’s a win-win,” said Pittsburgh NORML Chairman Isaac Holeva. “We want to give our supporters and all persons interested in this new legal industry the best chance to succeed. By attending this seminar, they will get expert advice and analysis from US Cannabis detailing both sides of the business: growing and producing marijuana and also medical regulation and compliance.”

These one-day seminars will give an extensive overview of the new Medical Marijuana Law, also known as Senate Bill 3, and how to invest or work in this new industry:

Pennsylvania Medical Marijuana System: What you need to know

 When and Where:

–   Saturday June 4th 2016   Philadelphia Marriott Downtown 

1201 Market Street   Philadelphia, PA 19107

–   Sunday June 5th 2016   Philadelphia Marriott West

111 Crawford Avenue   West Conshohocken, PA 19428

–  Saturday June 11th 2016   Pittsburgh Marriott City Center

112 Washington Place   Pittsburgh, PA 15219

–  Sunday June 12th 2016    Pittsburgh Marriott North

100 Cranberry Woods Drive   Cranberry Township, PA 16066

Time: 9:30am – 4pm  

Admission: $300.00 before 5/27/16 12:00 A.M.      $350.00 after 5/27/16 

Info and

US Cannabis Pharmaceutical Research and Development has been successfully operating in the legal United States cannabis industry since 2009.  This one-day seminar will provide an extensive overview of the following areas related to operating a legal medical marijuana business (and ancillary businesses) in Pennsylvania:

  • Review of the legal marijuana system in Pennsylvania (SB3) and the United States
  • Ins and outs of the Pennsylvania Grower/Processor and Dispensary application
  • Grower/Production and Dispensary selection and required zoning
  • Distribution profitability
  • Operational protocols 
  • Compliance and legal issues
  • Accounting, audits, banking and tax procedures
  • Investment/Fundraising opportunities
  • Human Resources 
  • Teambuilding (for grower/processor and dispensary applications)
  • Ancillary business opportunities (legal, transportation, security, real estate, insurance, marketing, accounting, plumbing, cleaning services, etc.)

About US Cannabis Pharmaceutical Research and Development:

Established for the purpose of developing the legal cannabis market across all platforms (education, production, research and development, management, consulting, and physician relations), US Cannabis Pharmaceutical Research and Development currently works with companies from all aspects of the cannabis/hemp industry throughout the United States and internationally, has developed patented growing systems, and provides educational seminars focusing on multiple aspects of the cannabis industry.

About Pittsburgh NORML

Pittsburgh NORML supports NORML’s mission of moving public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to criminal sanction.  To that end we are working in Western Pennsylvania to build support for medicinal marijuana laws and the repeal of marijuana criminal statutes.